# Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

> **NCT06171061** · PHASE4 · RECRUITING · sponsor: **Shandong First Medical University** · enrollment: 1200 (estimated)

## Conditions studied

- Chronic Coronary Syndrome

## Interventions

- **DRUG:** Yangxinshi tablet
- **OTHER:** Basic medication

## Key facts

- **NCT ID:** NCT06171061
- **Lead sponsor:** Shandong First Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-18
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171061, "Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06171061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*